Martin Bauer at Medical University of Vienna - Research Interests, Publications & Academic Profile

Martin Bauer

Medical University of Vienna

Austria

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do Korean students reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Pharmacology

70%

Pharmacotherapy

50%

Neuropharmacology

30%

Inflammatory Biology

20%

Antifungal Pharmacology

20%

Pharmacokinetic

20%

Pharmacometrics

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles10

Use of PET Imaging to Assess the Efficacy of Thiethylperazine to Stimulate Cerebral MRP1 Transport Activity in Wild-Type and APP/PS1-21 Mice

Article Link

Year:

2022

Impact of Cytochrome Induction or Inhibition on the Plasma and Brain Kinetics of [<sup>11</sup>C]metoclopramide, a PET Probe for P-Glycoprotein Function at the Blood-Brain Barrier

Article Link

Year:

2022

Topical niclosamide (ATx201) reduces Staphylococcus aureus colonization and increases Shannon diversity of the skin microbiome in atopic dermatitis patients in a randomized, double-blind, placebo-controlled Phase 2 trial.

Article Link

Year:

2022

Accelerator mass spectrometry for quantification of micro- and therapeutic dose diclofenac in microdialysis samples

Article Link

Year:

2022

Comparison of pharmacokinetics and stability of generics of cefepime, linezolid and piperacillin/tazobactam with their respective originator drugs: an intravenous bioequivalence study in healthy volunteers

Article Link

Year:

2022

Effect of the human endotoxin challenge on tedizolid tissue penetration

Article Link

Year:

2022

Influence of tedizolid on the cytokine response to the endotoxin challenge in healthy volunteers: a cross-over trial

Article Link

Year:

2022

Disrupted relationship between blood glucose and brain dopamine D2/3 receptor binding in patients with first-episode schizophrenia

Article Link

Year:

2021

Phase I Study to Assess Safety of Laser-Assisted Topical Administration of an Anti-TNF Biologic in Patients With Chronic Plaque-Type Psoriasis.

Article Link

Year:

2021

ABCB1 and ABCG2 Together Limit the Distribution of ABCB1/ABCG2 Substrates to the Human Retina and the <i>ABCG2</i> Single Nucleotide Polymorphism Q141K (c.421C> A) May Lead to Increased Drug Exposure.

Article Link

Year:

2021

Collaborators11

Jon Ulf Hansen

Statens Serum Institut

DENMARK

Rudolf Karch

Associate Professor

Medical University of Vienna

AUSTRIA

Anselm Jorda

Medical University of Vienna

AUSTRIA

Felix Bergmann

Medical University of Vienna

AUSTRIA

Heimo Lagler

Associate Professor

Medical University of Vienna

AUSTRIA

Severin Mairinger

Medical University of Vienna

AUSTRIA

Lukas Pezawas

Associate Professor

Medical University of Vienna

AUSTRIA

Nicolas Tournier

Université Paris-Saclay

FRANCE

Thomas Stimpfl

Medical University of Vienna

AUSTRIA

Oliver Langer

Associate Professor

Medical University of Vienna

AUSTRIA

Claudia Kuntner

Assistant Professor

Medical University of Vienna

AUSTRIA

How do Korean students reach out?

Meet Kite AI